Osimertinib in combination with bevacizumab in EGFR-Mutated NSCLC with leptomeningeal metastases.

ABSTRACT:

SUBMITTER: Jiang T 

PROVIDER: S-EPMC7815344 | biostudies-literature | 2020 Dec

REPOSITORIES: biostudies-literature